Booster Vaccine for Omicron Variant Gets Emergency Use Appro

The mRNA-based vaccine was developed using the indigenous platform technology by Gennova Biopharmaceuticals Ltd. and supported under the Mission COVID Suraksha, implemented by Biotechnology Industry Research Assistance Council (BIRAC).

Related Keywords

India , Hubspot , Gennova Biopharmaceuticals Under Mission Covid Suraksha , Gennova Biopharmaceuticals Ltd , Biotechnology Industry Research Assistance Council , Drug Control General , Gennova Biopharmaceuticals , Mission Covid , Booster Vaccine , Omicron , Emergency Use Approval , Mrna Vaccine ,